NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

NewAmsterdam Pharma aced the first in a cascade of Phase 3 readouts, showing that its lead cardio medicine took down levels of bad cholesterol. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NewAms­ter­dam suc­ceeds in the first of three key piv­otal stud­ies, pro­vid­ing hope to a trou­bled car­dio class